Acute Effect Of Aclidinium Bromide On Hyperinflation And Lung Volume Distribution In Patients With Severe COPD

被引:0
|
作者
Santus, P. [1 ]
Radovanovic, D. [1 ]
Di Marco, F. [2 ,3 ]
Raccanelli, R. [1 ]
Valenti, V. [3 ]
Centanni, S. [1 ]
机构
[1] Univ Milan, IRCCS Sci Inst Milan, Fdn Salvatore Maugeri, Pulm Rehabil Unit, Milan, Italy
[2] Univ Milan, Resp Unit, San Paolo Hosp, Milan, Italy
[3] Univ Milan, Resp Unit, Policlin San Donato, IRCCS San Donato Milanese, Milan, Italy
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5736
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Effect of Radiographic Phenotype on Dynamic Hyperinflation in Patients with Severe COPD.
    Marchetti, N.
    Civic, B.
    Criner, A. J.
    Criner, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [22] Aclidinium bromide provides long-acting bronchodilation in patients with COPD
    Chanez, P.
    Burge, P. S.
    Dahl, R.
    Creemers, J.
    Chuchalin, A.
    Lamarca, R.
    Gil, E. Garcia
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (01) : 15 - 21
  • [23] Safety And Tolerability Of Twice Daily Aclidinium Bromide In COPD Patients: Accord COPD I
    D'Urzo, A.
    Make, B. J.
    Kerwin, E. M.
    Rekeda, L.
    Teresa Sanz, M.
    Caracta, C.
    Maurer, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] The effect of inspiratory muscle training on lung hyperinflation in COPD patients.
    Meshcherykova, Natalia
    Belevsky, Andrey
    Cherniak, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [25] Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [26] Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD
    Beeh, Kai-Michael
    Wagner, Frank
    Khindri, Sanjeev
    Drollmann, Anton Franz
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 8 (05) : 340 - 345
  • [27] Long-term Cardiovascular Safety of Aclidinium Bromide in Patients With COPD
    Donohue, James
    Tashkin, Donald
    Ferguson, Gary
    Kowey, Peter
    Rekeda, Ludmyla
    Shrestha, Pomy
    Gil, Esther Garcia
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
  • [28] Aclidinium Bromide Treatment in Patients Receiving Beta-Blockers: Effects on MACE, Moderate/Severe COPD Exacerbations, and Lung Function in Patients with Moderate-to-Very Severe COPD and Cardiovascular Risk Factors (ASCENT-COPD)
    Chapman, K. R.
    Wise, R. A.
    Scirica, B. M.
    Bhatt, D. L.
    Daoud, S. Z.
    Lythgoe, D.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
    McGarvey, Lorcan
    Morice, Alyn H.
    Smith, Jaclyn A.
    Birring, Surinder S.
    Chuecos, Ferran
    Seoane, Beatriz
    Jarreta, Diana
    BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
  • [30] Combining CT and spirometry to determine hyperinflation in COPD patients for lung volume reduction eligibility
    Klooster, Karin
    Bakker, Jens
    Hartman, Jorine E.
    Slebos, Dirk-Jan
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64